Semaglutide improved maximum walking distance in patients with type 2 diabetes and symptomatic peripheral artery disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback